Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $581.4600 (-0.16%) ($574.4500 - $586.2900) on Fri. Jul. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 29 | Latest Price | $581.4600(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) DIA(37%) IWD(34%) SPLV(33%) SPY(32%) | Factors Impacting REGN price | REGN will decline at least -0.995% in a week (0% probabilities). TBT(-10%) VIXM(-9%) UUP(-6%) VXX(-1%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $595.91 | 5 Day Moving Average | $584.32(-0.49%) | 10 Day Moving Average | $587.49(-1.03%) | 20 Day Moving Average | $595.91(-2.42%) | To recent high | -16% | To recent low | 6.2% | Market Cap | $61.651b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |